Source link : https://www.newshealth.biz/health-news/fda-approves-datroway-for-pretreated-advanced-breast-cancer/
The FDA approved datopotamab deruxtecan (Datroway) for adults with unresectable or metastatic, hormone receptor (HR)-positive/HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease. Efficacy of the Trop2-directed antibody and topoisomerase inhibitor conjugate was evaluated in the multicenter TROPION-Breast01 trial, which included 732 patients randomized to datopotamab deruxtecan or […]
Author : News Health
Publish date : 2025-01-17 20:44:52
Copyright for syndicated content belongs to the linked Source.